IMDC Special Meeting Agenda 121709

NOTICE OF CHANGE OF DATE RELATING TO
SPECIAL MEETING OF ILLINOIS MEDICAL DISTRICT COMMISSION

PLEASE TAKE NOTICE that the Illinois Medical District Commission, of 600 South Hoyne Avenue, Chicago, Illinois, 60612 herewith gives notice that the Special Meeting of the Illinois Medical District Commission previously scheduled for Thursday, December 10, 2009, at 8:30 A.M, has been changed to Thursday, December 17, 2009 at 1:00 P.M. at the Illinois Medical District Commission, Conference Room, 600 S Hoyne Ave., Chicago, Illinois.  This notice is being provided pursuant to and in compliance with the Illinois Open Meetings Act.  The purpose of the said meeting is for discussion and action upon the proposed leasing to Costco of a site bounded by Ashland Avenue, Hastings Street, 15^th Street and the CTA elevated line located just west of Paulina Street, Chicago, Illinois and the potential acquisition of property located within the District Development Area of the Illinois Medical District.

Dated: December 8, 2009

MEETING OF ILLINOIS MEDICAL DISTRICT COMMISSION

IMDC Agenda – July 27,2010

MEETING OF ILLINOIS MEDICAL DISTRICT COMMISSION

IMDC Meeting Agenda – April 27,2010

Date updated: April 27, 2010

IMDC Meeting Agenda-12610

MEETING OF ILLINOIS MEDICAL DISTRICT COMMISSION

Date updated: January 20, 2010

The award is given to leaders in the field of refractive, cornea, cataract and lens-based surgery. It is named for Leedert J. Lans, a renowned ophthalmology researcher who defined the basics of refractive surgery – surgery that corrects problems of visual acuity.

Read more…

The National Institutes of Health awarded the five-year, $3.8-million grant to Rush University Medical Center, University of Illinois at Chicago Medical Center and Cook County’s health system, which includes Stroger Hospital. The three hospitals share the Illinois Medical District campus, which also is home to the Ruth M. Rothstein CORE Center, one of the largest HIV clinics in the Midwest.

Read more…

The studies appear online and will be published in an upcoming issue of Menopause, the journal of The North American Menopause Society.

In the first study, the botanicals black cohosh and red clover were compared to the standard of care — hormone therapy — and to placebo for the treatment of hot flashes.

The researchers enrolled 89 women with moderate to severe hot flashes in a four-arm, randomized, double-blind clinical trial. The women, who experienced at least 35 hot flashes and night sweats per week, were followed for 12 months. They kept diaries to record the number of hot flashes per day as well as the intensity.

The researchers found that the average number of hot flashes per week decreased over time across all groups — black cohosh decreased 34 percent, red clover 57 percent, placebo 63 percent and hormone therapy 94 percent.

“The important message is that all women improved, but there was a large placebo effect, and the botanicals did not work significantly better than placebo,” said Stacie Geller, the G. William Arends Professor of Obstetrics and Gynecology at UIC and lead author of the study. “As expected, hormone therapy, considered the gold standard, significantly reduced hot flashes when compared with placebo,” Geller said.

“We also found that the botanicals were safe — which is important, since many women will still continue to use them.”

Geller and colleagues from the UIC/National Institutes of Health Center for Botanical Dietary Supplements Center reported no significant differences between botanical treatments and placebo for any of the safety parameters, including breast and endometrial safety, liver enzymes, complete blood count, or lipid profiles.

In a second study, UIC and Northwestern researchers enrolled 66 women from the parent trial to determine whether the botanic treatments had an effect on cognitive abilities, particularly verbal memory. It is the first study to evaluate the cognitive effects of black cohosh.

The women completed baseline cognitive testing before receiving treatment and again during the 12-month treatment to measure the recollection of words and short stories. They also wore monitors that measured changes in skin conductance during a hot flash. Both subjective and objective hot flashes were recorded during a 24-hour period.

The study, like the main trial, found that none of the botanicals had either a beneficial or a detrimental effect on memory. The specific hormone therapy used in the trial, Prempro, had a slight negative impact on memory.

“Together, these two studies demonstrate that compared to botanicals, only hormone therapy had a beneficial effect on vasomotor symptoms, but this benefit was at the cost of a slight decrease in memory,” said Pauline Maki, UIC associate professor of psychiatry and psychology and lead author of the cognition study. The focus of ongoing research at UIC, Maki said, is to identify a safe and effective treatment for hot flashes that is either neutral or beneficial to memory functioning.

Norman Farnsworth, who heads the UIC/NIH Botanical Center, notes that the center continues to study botanicals for their safety and efficacy in maintaining women’s health and well-being. The center is supported by a grant from the NIH Office of Dietary Supplements, the NIH National Center for Complementary and Alternative Medicine, UIC, and the UIC College of Pharmacy. Additional support for the clinical trial came from the Naturex, Inc. of Hackensack, N.J. and Pharmavite LLC of Mission Hills, Calif.

Co-authors of the primary safety and efficacy study include Lee Shulman, Suzanne Banuvar and Geena Epstein of Northwestern University Feinberg School of Medicine, and Richard van Breemen, Ying Zhou, Samad Hedayat, Dejan Nikolic, Elizabeth Krause, Colleen Piersen, Judy Bolton, Guido Pauli and Farnsworth of UIC.

Co-authors of the cognitive study include Banuvar and Shulman of Northwestern and Leah Rubin, Deanne Fornelli and Lauren Drogos of UIC.

An extended interview as MP3 audio file is at https://blackboard.uic.edu/bbcswebdav/institution/web/news/podcasts/PdCst66-Aug6%2709-Maki.mp3

For more information about UIC, visit www.uic.edu
CONTACT: Sherri McGinnis Gonzalez, (312) 996-8277, smcginn@uic.edu

——-

NOTICE OF SPECIAL MEETING OF
ILLINOIS MEDICAL DISTRICT COMMISSION

PLEASE TAKE NOTICE that the Illinois Medical District Commission, of 600 South Hoyne Avenue, Chicago, Illinois, 60612-3756 will conduct a special meeting of the Illinois Medical District Commission, which meeting is in addition to those meetings as previously posted by the Commission, which meeting shall occur on Wednesday, July 22, 2009, at 9:00 A.M., at the Illinois Medical District Commission, Conference Room, 600 South Hoyne Avenue, Chicago, Illinois. This special meeting has been called by the President of the Commission, Kenneth D. Schmidt.  This notice is being provided pursuant to and in compliance with the Illinois Open Meetings Act, 5 ILCS 120.  The purpose of the special meeting is for discussion and action upon the Chicago Technology Park Research Center Lease with the Board of Trustees of the University of Illinois and discussion and action relative to the 2020 W. Ogden Lease and Redevelopment Agreement.

Dated:  July 10, 2009